menu ☰
menu ˟

Heplisav-B HBV vaccine for adults available in US

12 Jan 2018
Dynavax announced in a recent press release its hepatitis B vaccine, Heplisav-B, is now available in the U.S.“Dynavax is prepared and proud to launch our first product, Heplisav-B, in the United States,” Eddie Gray, CEO of Dynavax, said in the pr...

Click here to view the full article which appeared in Hepatology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.